The Longitudinal PTH-Study

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

December 5, 2018

Study Completion Date

August 7, 2019

Conditions
CKD-MBD - Chronic Kidney Disease Mineral and Bone DisorderSecondary HyperparathyroidismKidney Replacement
Interventions
DIAGNOSTIC_TEST

One armed study, blood from each patient is analysed by four assays ( two 3rd generation and two 2nd generation assays)

Intact PTH Assay (Siemens Healthcare Diagnostics Inc); LIAISON 1-84 PTH Assay (Diasorin); PTH (1-84), biointact (Roche Diagnostics); PTH, intact (Roche Diagnostics)

Trial Locations (1)

1090

Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03464149 - The Longitudinal PTH-Study | Biotech Hunter | Biotech Hunter